1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with compstatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; DeAngelis, RA; Hajishengallis, E; Hajishengallis, G; Hosur, KB; Lambris, JD; Maekawa, T; Ricklin, D | 1 |
| Hilkin, BM; Lambris, JD; Nester, CM; Ricklin, D; Shao, D; Smith, RJ; Zhang, Y | 1 |
2 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and compstatin
| Article | Year |
|---|---|
Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.
Topics: Animals; Bacteroidaceae Infections; Bone Resorption; Complement C3; Disease Models, Animal; Female; Humans; Inflammation Mediators; Macaca fascicularis; Male; Mice; Osteoclasts; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones | 2014 |
Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy.
Topics: Animals; Cattle; Cells, Cultured; Complement C3; Complement C3-C5 Convertases; Complement Pathway, Alternative; Erythrocytes; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; Peptides, Cyclic; Primates; Pyridones; Sheep | 2015 |